Privia Health Group, Inc.

For the period ended Dec 31, 2025. Filed Feb 27, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 27, 2026

PRVA$24.54+0.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

		Privia Health Group, Inc.
Date:	February 27, 2026	By:	/s/ Parth Mehrotra
			Name: Parth Mehrotra
			Title: Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Parth Mehrotra
Signature	Title	Date
/s/ Parth Mehrotra	Chief Executive Officer and Director(principal executive officer)	February 27, 2026
/s/ David Mountcastle	Executive Vice President and Chief Financial Officer(principal financial and accounting officer)	February 27, 2026
David Mountcastle
/s/ Lance Berberian	Director	February 26, 2026
Lance Berberian
/s/ Nancy Cocozza	Director	February 27, 2026
Nancy Cocozza
/s/ Pamela Kimmet	Director	February 27, 2026
Pamela Kimmet
/s/ David King	Director	February 27, 2026
David King
/s/ Thomas McCarthy	Director	February 27, 2026
Thomas McCarthy
/s/ Shawn Morris	Director	February 27, 2026
Shawn Morris
/s/ Jaewon Ryu	Director	February 27, 2026
Jaewon Ryu, M.D.
/s/ David Wichmann	Director	February 27, 2026
David Wichmann

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.